Myristicin, CAS 607-91-0

Product Description: Myristicine is an orally bioavailable serotonin receptor antagonist and weak monoamine oxidase (MAO) inhibitor. Myristicine also exerts anti-cancer effects on gastric cancer cells by inhibiting the EGFR/ERK signaling pathway. Myristicine is the main component of nutmeg essential oil and has anti-cancer, anti-proliferative, antibacterial, anti-inflammatory and apoptosis-inducing effects. Myristicine abuse can produce hallucinogenic effects, organ damage, etc[1][2][3][4].

Applications: Neuroscience-Neuromodulation

Formula: C11H12O3

References: [1]Kalbhen DA, et al. Nutmeg as a narcotic. A contribution to the chemistry and pharmacology of nutmeg (Myristica fragrans).Angew Chem Int Ed Engl. 1971 Jun;10(6):370-4./[2]Dawidowicz AL, et al. Simple and rapid determination of myristicin in human serum.Forensic Toxicol. 2013 Jan;31(1):119-123. Epub 2012 Aug 15./[3]Badr G, Elsawy H, Amalki M A, et al. Protective effects of myristicin against ulcerative colitis induced by acetic acid in male mice[J]. Food and Agricultural Immunology, 2020, 31(1): 435-446./[4]Song J, et al. Myristicin Suppresses Gastric Cancer Growth via Targeting the EGFR/ ERK Signaling Pathway. Curr Mol Pharmacol. 2023;16(7):712-724.

CAS Number: 607-91-0

Molecular Weight: 192.21

Compound Purity: 99.89

Research Area: Cancer; Infection; Inflammation/Immunology; Neurological Disease

Solubility: DMSO : 100 mg/mL (ultrasonic)

Target: 5-HT Receptor;Apoptosis;Bacterial;EGFR;ERK

• Artikelnummer: MEXHY-N2510-100
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-N2510-100
• Green Labware: Nein
• Verpackungseinheit: 100 mg
• Mengeneinheit: STK